DIGOXIN tablet United States - English - NLM (National Library of Medicine)

digoxin tablet

ncs healthcare of ky, inc dba vangard labs - digoxin (unii: 73k4184t59) (digoxin - unii:73k4184t59) - heart failure: digoxin is indicated for the treatment of mild to moderate heart failure. digoxin increases left ventricular ejection fraction and improves heart failure symptoms as evidenced by exercise capacity and heart failure symptoms as evidenced by exercise capacity and heart failure-related hospitalizations and emergency care, while having no effect on mortality. where possible, digoxin should be used with a diuretic and an angiotensin-converting enzyme inhibitor, but an optimal order for starting these three drugs cannot be specified. atrial fibrillation: digoxin is indicated for the control of ventricular response rate in patients with chronic atrial fibrillation. digitalis glycosides are contraindicated in patients with ventricular fibrillation or in patients with a known hypersensitivity to digoxin. a hypersensitivity reaction to other digitalis preparations usually constitutes a contraindication to digoxin.

DIGOXIN tablet United States - English - NLM (National Library of Medicine)

digoxin tablet

amneal pharmaceuticals ny llc - digoxin (unii: 73k4184t59) (digoxin - unii:73k4184t59) - heart failure: digoxin is indicated for the treatment of mild to moderate heart failure. digoxin increases left ventricular ejection fraction and improves heart failure symptoms as evidenced by exercise capacity and heart failure symptoms as evidenced by exercise capacity and heart failure-related hospitalizations and emergency care, while having no effect on mortality. where possible, digoxin should be used with a diuretic and an angiotensin-converting enzyme inhibitor, but an optimal order for starting these three drugs cannot be specified. atrial fibrillation: digoxin is indicated for the control of ventricular response rate in patients with chronic atrial fibrillation. digitalis glycosides are contraindicated in patients with ventricular fibrillation or in patients with a known hypersensitivity to digoxin. a hypersensitivity reaction to other digitalis preparations usually constitutes a contraindication to digoxin.

LANOXIN INJECTION 0.5 mg2 ml Singapore - English - HSA (Health Sciences Authority)

lanoxin injection 0.5 mg2 ml

dch auriga singapore - digoxin - injection - 0.5 mg/2 ml - digoxin 0.5 mg/2 ml

Digoxin/Anfarm Injectable Solution 0.5mg/2ml Malta - English - Medicines Authority

digoxin/anfarm injectable solution 0.5mg/2ml

anfarm hellas s.a. - digoxin - solution for infusion or injection - digoxin 0.5 milligram(s)/2 millilitre - cardiac therapy

Digoxin 250mcgs/ml solution for injection Malta - English - Medicines Authority

digoxin 250mcgs/ml solution for injection

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - digoxin - solution for injection - digoxin 250 µg/ml - cardiac therapy

Digoxin Zentiva 0.5mg/2ml Solution for Injection Malta - English - Medicines Authority

digoxin zentiva 0.5mg/2ml solution for injection

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - digoxin - solution for injection - digoxin 0.50 mg/2ml - cardiac therapy

DIGOX- digoxin tablet United States - English - NLM (National Library of Medicine)

digox- digoxin tablet

proficient rx lp - digoxin (unii: 73k4184t59) (digoxin - unii:73k4184t59) - digoxin 125 ug - heart failure: digoxin is indicated for the treatment of mild to moderate heart failure. digoxin increases left ventricular ejection fraction and improves heart failure symptoms as evidenced by exercise capacity and heart failure symptoms as evidenced by exercise capacity and heart failure-related hospitalizations and emergency care, while having no effect on mortality. where possible, digoxin should be used with a diuretic and an angiotensin-converting enzyme inhibitor, but an optimal order for starting these three drugs cannot be specified. atrial fibrillation: digoxin is indicated for the control of ventricular response rate in patients with chronic atrial fibrillation. digitalis glycosides are contraindicated in patients with ventricular fibrillation or in patients with a known hypersensitivity to digoxin. a hypersensitivity reaction to other digitalis preparations usually constitutes a contraindication to digoxin.

LANOXIN digoxin injection solution United States - English - NLM (National Library of Medicine)

lanoxin digoxin injection solution

covis pharmaceuticals, inc. - digoxin (unii: 73k4184t59) (digoxin - unii:73k4184t59) - digoxin 250 ug in 1 ml

DIGOXIN solution United States - English - NLM (National Library of Medicine)

digoxin solution

precision dose, inc. - digoxin (unii: 73k4184t59) (digoxin - unii:73k4184t59) - digoxin 0.05 mg in 1 ml

DIGOX- digoxin tablet United States - English - NLM (National Library of Medicine)

digox- digoxin tablet

aidarex pharmaceuticals llc - digoxin (unii: 73k4184t59) (digoxin - unii:73k4184t59) - digoxin 250 ug - heart failure: digoxin is indicated for the treatment of mild to moderate heart failure. digoxin increases left ventricular ejection fraction and improves heart failure symptoms as evidenced by exercise capacity and heart failure symptoms as evidenced by exercise capacity and heart failure-related hospitalizations and emergency care, while having no effect on mortality. where possible, digoxin should be used with a diuretic and an angiotensin-converting enzyme inhibitor, but an optimal order for starting these three drugs cannot be specified. atrial fibrillation: digoxin is indicated for the control of ventricular response rate in patients with chronic atrial fibrillation. digitalis glycosides are contraindicated in patients with ventricular fibrillation or in patients with a known hypersensitivity to digoxin. a hypersensitivity reaction to other digitalis preparations usually constitutes a contraindication to digoxin.